ICD-10-CM Billable Code

C32.3

Malignant neoplasm of laryngeal cartilage

Clinical Classification Guidelines

Medical Intelligence & Overview

Malignant neoplasm of the laryngeal cartilage, classified under ICD-10 code C32.3, refers to a cancerous growth that originates in the cartilage of the larynx, commonly known as the voice box. This type of cancer is a rare form of laryngeal cancer, which can impact speech, breathing, and swallowing. Early diagnosis and treatment are crucial for improving prognosis and quality of life for affected individuals.

Causes & Symptoms

Clinical Causes: Tobacco use, including smoking cigarettes and cigars Heavy alcohol consumption Exposure to certain environmental carcinogens such as asbestos or industrial pollutants Human papillomavirus (HPV) infection in some cases Chronic laryngeal inflammation or irritation from voice overuse or other factors A history of radiation exposure to the head and neck area

Key Symptoms: Persistent sore throat or hoarseness Difficulty swallowing or a sensation of a lump in the throat Ear pain or discomfort Unexplained weight loss Difficulty breathing or noisy breathing A visible mass or swelling in the neck Coughing, sometimes with blood Changes in voice quality, sounding more hoarse or strained

Diagnostic & Treatment

Diagnosis Path: Diagnosing malignant neoplasm of the laryngeal cartilage involves a combination of medical history assessment, physical examination, and diagnostic tests. These may include: - Endoscopic laryngoscopy: Insertion of a thin, flexible tube with a camera into the throat to visualize the larynx and identify abnormalities. - Imaging studies: Such as CT scans, MRI, or PET scans to determine the location, size, and extent of the tumor. - Biopsy: A tissue sample obtained during endoscopy to confirm malignancy and determine the type of cancer. - Additional tests: May include blood work or other imaging to evaluate overall health and rule out metastasis. Early detection is important for effective management of this condition.

Treatment Protocols: Treatment options for malignant neoplasm of the laryngeal cartilage depend on the tumor's size, location, stage, and the patient’s overall health. Common approaches include: - Surgical removal: Resection of the tumor, which may range from partial laryngectomy to complete removal of the larynx in advanced cases. - Radiation therapy: Using high-energy rays to target and destroy cancer cells, often used in combination with surgery or for inoperable tumors. - Chemotherapy: Medications to kill cancer cells, sometimes used alongside other treatments or in cases with metastasis. - Targeted therapy and immunotherapy: Emerging treatments that focus on specific molecules or immune responses involved in cancer growth. Rehabilitation, including speech and swallowing therapy, may be necessary following treatment to improve functional outcomes.

Reimbursement claims with a date of service on or after October 1, 2015 require the use of ICD-10-CM codes.

Clinical Advice & FAQs

Billing Guidance

Is C32.3 a billable ICD-10 code?
Yes, C32.3 is a specific, billable code that can be used to indicate a diagnosis for reimbursement purposes.

Documentation

How do I report C32.3?
Clinical documentation must specify the nature of Malignant neoplasm of laryngeal cartilage and any associated comorbidities for accurate reporting.

Cite this Clinical Reference

Related Diagnosis Codes

Clinical Meta Tags

laryngeal neoplasm malignant cartilage